Oral peptide delivery platform

About Arecor

Arecor is a UK-based biopharma company utilizing its Arestat® formulation technology to create superior drug products in diabetes and cardiometabolic diseases. The company has a dual strategy: advancing its own clinical-stage pipeline of next-generation insulins and developing an oral peptide delivery platform, while also generating revenue through technology licensing partnerships. With one partnered product already on the market generating royalties and a robust intellectual property portfolio, Arecor aims to improve patient outcomes through enhanced drug delivery.

Therapeutic Areas